Liquidia Corporation share price logo

Liquidia Corporation

NASDAQ: LQDA

Mid Cap

$78.17

+1.25

(+1.63%)

as on

Liquidia Corporation Stock Performance

as on June 27, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $76.51
    $79.41
    downward going graph

    2.12%

    Downside

    1.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $11.85
    $78.25
    downward going graph

    84.84%

    Downside

    0.10%

    Upside

    downward going graph

Liquidia Corporation share price movements today

Previous Close
$76.92
Open
$76.54
Volume
1.5M
Day's Low - High
$76.51 - $79.41
52 Week Low - High
$11.85 - $78.25

Liquidia Corporation Historical Returns

1 Month Return
+ 28 %
3 Month Return
+ 109.19 %
1 Year Return
+ 499.53 %
3 Year Return
+ 755.62 %
5 Year Return
0 %

Liquidia Corporation Stock Fundamentals & Key Indicators

Check Liquidia Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.7B

EPS (TTM)

3.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

444.35

Industry PE ratio

16.522

PEG Ratio

0

EBITDA

46.6M

Revenue (TTM)

288.1M

Profit Margin

7.74%

Return On Equity TTM

28.18%

Liquidia Corporation Stock Valuation

Track how Liquidia Corporation P/E has moved over time to understand its valuation trends.

Liquidia Corporation in the last 5 years

  • Overview

  • Trends

Lowest (-34.30x)

December 31, 2025

Industry (16.52x)

June 26, 2026

Today (444.35x)

June 26, 2026

Highest (-5.46x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 444.35x

Liquidia Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Liquidia Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Liquidia Corporation image
Liquidia Corporation
BUY$6.7BNA444.357.74%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.3B201.88%20.1240.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$18.3B10.3%NA-2.04%3.1199999999999997%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$40.7BNA18.8415.11%2.09%
ZOETIS INC. image
ZOETIS INC.
BUY$32.8B-58.44%12.8128.04%2.64%
See all

Stock Returns calculator for Liquidia Corporation Stock including INR - Dollar returns

The Liquidia Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Liquidia Corporation investment value today

Current value as on today

₹6,70,886

Returns

₹5,70,886

(+570.89%)

Returns from Liquidia Corporation Stock

₹5,09,275 (+509.28%)

Dollar Impact

₹61,610 (+61.61%)

Analyst Recommendation on Liquidia Corporation Stock

Based on 13 analysts

BUY

84.62%

Buy

7.69%

Hold

7.69%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Liquidia Corporation. Average target price of $72.38

Liquidia Corporation Share Price Target

Get share price movements and forecasts by analysts on Liquidia Corporation.

What analysts predicted

-8%DOWNSIDE

Target Price

$72.38

Current Price

$78.17

Analyzed by

13 Analysts

Target

$72.38

Liquidia Corporation target price $72.38, a slight downside of -8% compared to current price of $78.17. According to 13 analysts rating.

Indian Investors' Interest in Liquidia Corporation Stock

Search interest for Liquidia Corporation Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:19% versus previous 30 day period

Liquidia Corporation Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
4
2
3
4
2
3
8
54
92
132
Gross Profit
3
1
2
2
1
1
7
51
84
120
Operating Income
-26
-28
-27
-29
-36
-35
-37
1
19
61
EBITDA
-24
-37
-24
-19
-33
-33
-35
3
21
63
Interest Expense
1
2
2
2
4
4
5
6
6
6
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-40
-27
-23
-38
-38
-41
-3
14
56
Income Tax Expense
-2
0
-
-
-
-
-
-
-
3
Net Income
-27
-40
-27
-23
-38
-38
-41
-3
14
52
Net Profit Margin
-605.83%
-1377.12%
-763.65%
-520.57%
-1315.36%
-1229.71%
-470.51%
-6.50%
15.82%
39.79%

Liquidia Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
13
7
2
8
0
12
15
17
13
158
Gross Profit
12
6
2
7
0
9
13
14
8
145
Operating Income
-15
-28
-34
-46
-59
-33
-38
-73
-121
-51
EBITDA
-15
-15
-32
-43
-55
-28
-35
-70
-115
-43
Interest Expense
0
13
18
1
0
0
2
6
12
24
Depreciation
-
0
1
2
3
5
3
2
2
1
Income Before Tax
-15
-29
-53
-47
-59
-34
-41
-78
-130
-68
Income Tax Expense
0
13
0
-1
-2
-4
-2
-2
-
-
Net Income
-15
-29
-53
-47
-59
-34
-41
-78
-130
-68
Net Profit Margin
-120.56%
-401.68%
-1962.92%
-589.48%
-8080.11%
-269.03%
-257.39%
-448.89%
-931.65%
-43.53%

Liquidia Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-30
-27
-23
-38
-38
-41
-3
14
52
Operating Cash Flow
-24
-22
-25
-20
-30
-39
-9
44
52
Investing Cash Flow
0
-1
-1
-4
0
-1
0
-4
-2
Financing Cash Flow
99
0
98
-2
24
47
-5
-7
-18
Change in Cash
74
-24
71
-27
-6
7
-15
33
32

Liquidia Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-53
-47
-59
-34
-41
-78
-130
-68
Operating Cash Flow
-24
-31
-48
-54
-34
-28
-41
-93
-35
Investing Cash Flow
-2
0
-1
0
0
0
-11
-8
-6
Financing Cash Flow
28
68
66
63
26
64
43
194
59
Change in Cash
1
36
16
9
-7
35
-9
92
14

Global Institutional Holdings in Liquidia Corporation

Funds
Holdings
TANG CAPITAL MANAGEMENT LLC
1.3%
CenterBook Partners LP
1.28%
T. Rowe Price Associates, Inc.
1.07%
Patient Square Capital
1.18%
Eversept Partners, LP
0.76%
See all

Liquidia Corporation News & Key Events

  • img

    Today's Timeline - 19 June

    Fri, 05:34 PM

    -

    Liquidia Corporation's EPS estimates for 2026 and 2027 have significantly increased, with shares up 106.1% year to date.

Insights on Liquidia Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LQDA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LQDA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 2.91M → 132.86M (in $), with an average increase of 45.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -41.57M → 52.86M (in $), with an average increase of 424.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LQDA stock has moved up by 10.0%

About Liquidia Corporation

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
OrganisationLiquidia Corporation
Headquarters419 Davis Drive, Morrisville, NC, United States, 27560
IndustryDrug Manufacturers - Specialty & Generic
CEODr. Roger A. Jeffs Ph.D.
E-voting on sharesClick here to vote

Key Management of Liquidia Corporation

Name

Title

Ms. Dana Boyle

Chief Accounting Officer

Matt Snow

Senior Vice President of Sales

Dr. Roger A. Jeffs Ph.D.

CEO & Director

Dr. Rajeev Saggar M.D.

Chief Medical Officer

Mr. Scott Moomaw

Chief Commercial Officer

Mr. Christian Perez Font

Senior VP, Chief Compliance Officer & Associate General Counsel

Mr. Michael Post

Senior Vice President of Marketing

Ms. Sarah Krepp SPHR

Chief Human Resources Officer

Mr. Michael Kaseta

COO & CFO

Mr. Russell Schundler

General Counsel & Corporate Secretary

FAQs

What is Liquidia Corporation share price today?

Liquidia Corporation share price today is $78.17 as on at the close of the market. Liquidia Corporation share today touched a day high of $79.41 and a low of $76.51.

What is the 52 week high and 52 week low for Liquidia Corporation share?

Liquidia Corporation share touched a 52 week high of $78.25 on and a 52 week low of $11.85 on . Liquidia Corporation stock price today i.e. is closed at $78.17,which is 0.10% down from its 52 week high and 559.66% up from its 52 week low.

What is Liquidia Corporation's market capitalisation today?

Liquidia Corporation market capitalisation is $0.01T as on .

How to invest in Liquidia Corporation Stock (LQDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Liquidia Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Liquidia Corporation Shares that will get you 0.0192 shares as per Liquidia Corporation share price of $78.17 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Liquidia Corporation Stock (LQDA) from India?

Indian investors can start investing in Liquidia Corporation (LQDA) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Liquidia Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Liquidia Corporation share’s latest price of $78.17 as on June 27, 2026 at 8:45 am IST, you will get 0.1279 shares of Liquidia Corporation. Learn more about fractional shares .